A combination of BRAF and MEK inhibitors plus immunotherapy improved progression-free but not overall survival, compared to dual immune checkpoint blockade.

Canadian scientists have identified a promising therapeutic target to attack to prevent breast cancer from recurring: the ...

Darolutamide (Nubeqa) is granted FDA approval for metastatic castration-sensitive prostate cancer, enhancing survival and ...

First-line treatment with sacituzumab govitecan plus pembrolizumab showed significant improvement in PFS vs. chemotherapy ...

A combination drug treatment doubled survival time for patients with an aggressive form of colorectal cancer, according to ...

Patritumab deruxtecan demonstrated activity against brain metastases and leptomeningeal disease in a phase 2 trial of patients with advanced cancers.

Learn about stomach cancer symptoms, causes, and treatments. Recognising early signs like bloating or pain can improve ...

Malignant tumors must be treated ... or more rarely in other types of tissue — are the most common type of primary tumor found in the chest wall. Carcinoid tumors are rare cancers that most often ...

Surgery is typically the first-choice treatment for carcinoid cancer, with the goal of removing the entire tumor, if possible, and debulking (removing as much as possible) metastases (spread of cancer ...

Only one (5%) patient died due to liver metastases of the duodenal carcinoid. Conclusions Duodenal carcinoids are rare and indolent tumors usually associated with a benign progression. Duodenoscopy, ...

However, some patients experience aggressive growth and spread (metastasis ... now discovered that the progression of pulmonary carcinoid tumors is linked to activation of the TERT (telomerase ...

The agent is also indicated for long-term treatment of severe diarrhea among adults with metastatic carcinoid tumors or those experiencing profuse watery diarrhea tied to vasoactive intestinal ...